Innovation You Can Trust

of MedTech excellence.

delivery reliability in our direct markets.

annual revenue reinvested in R&D.

We believe that high-end medical technology is key to advancing the treatment of vascular disease and improving patient health.

We deliver innovative, trusted products and outstanding services that advance endovascular treatment for aortic and peripheral vascular disease—enabling healthcare professionals to improve patient outcomes. 

We don’t believe in universal solutions. Our R&D team focuses on developing dedicated devices for distinct clinical needs—innovations born from real challenges, not market trends.

Recent product launches such as BeGraft+, BeFlared, BeFlow, and the FEVAR indication for BeGraft are proof of that mindset in action: developing solutions that enable physicians to treat patients with confidence.

In a changing regulatory landscape, our strength lies in agility. We meet the highest standards of safety and performance while continuing to explore what’s next. Compliance and creativity go hand in hand—both are essential to sustaining trust and progress.

At our 15th anniversary, a patient in his fifties shared how a covered stent had saved his life—not in abstract numbers, but in the ability to walk his daughter down the aisle. For many of us, it was the most powerful reminder of our purpose.

A vascular surgeon once described using a Bentley stent as “choosing certainty when everything else feels unpredictable.” That trust, earned through precision and consistency, reflects the culture we live every day.

During a recent product training, a young physician shared that Bentley’s devices had given him the confidence to perform his first complex aortic case independently—a milestone for him, and a quiet moment of pride for us.